Timo Damm Selected Research

CS1 peptide

1/2017

An O-Glycosylation of Fibronectin Mediates Hepatic Osteodystrophy Through α4β1 Integrin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Timo Damm Research Topics

Disease

2	Breast Neoplasms (Breast Cancer) 01/2020 - 03/2017
2	Neoplasm Metastasis (Metastasis) 01/2020 - 03/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2020
1	Neoplasms (Cancer) 12/2020
1	Bone Diseases (Bone Disease) 03/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Multiple Myeloma 01/2017
1	Liver Diseases (Liver Disease) 01/2017

Drug/Important Bio-Agent (IBA)

1	Pharmaceutical PreparationsIBA 12/2020
1	Liposomes (Liposome)IBA 12/2020
1	Therapeutic UsesIBA 12/2020
1	Tyrosine (L-Tyrosine)FDA Link 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Dasatinib (BMS 354825)FDA Link 01/2020
1	CSK Tyrosine-Protein KinaseIBA 01/2020
1	Diphosphonates (Bisphosphonates)IBA 03/2017
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 03/2017
1	5-fluoro-2'-deoxyuridineIBA 03/2017
1	5-FdU-alendronateIBA 03/2017
1	AntimetabolitesIBA 03/2017
1	Protein Isoforms (Isoforms)IBA 01/2017
1	ElementsIBA 01/2017
1	CS1 peptideIBA 01/2017
1	IntegrinsIBA 01/2017

Therapy/Procedure

2	Therapeutics 12/2020 - 03/2017
1	Precision Medicine 12/2020
1	Drug Therapy (Chemotherapy) 12/2020
1	Chemoprevention 03/2017